Search clinical trials for: AMN107- NILOTINIB
Total 3032 results
-
Guangzhou University of Traditional Chinese MedicineGuangdong Provincial Hospital of Traditional Chinese MedicineRecruitingAdvanced Colorectal CancerChina
-
Liu ZhenhuaNot yet recruitingExtensive Stage Small Cell Lung CancerChina
-
Peking Union Medical College HospitalNot yet recruitingAnlotinib | Advanced Esophageal Squamous Cell Cancer | SHR-1210
-
Huashan HospitalActive, not recruiting
-
Chia Tai Tianqing Pharmaceutical Group Co., Ltd.UnknownGynecological CancerChina
-
Chia Tai Tianqing Pharmaceutical Group Co., Ltd.UnknownMSI-H or dMMR Advanced Solid TumorsChina
-
Chia Tai Tianqing Pharmaceutical Group Co., Ltd.UnknownAdvanced Acral Malignant MelanomaChina
-
Chia Tai Tianqing Pharmaceutical Group Co., Ltd.Unknown
-
Sichuan Cancer Hospital and Research InstituteRecruitingGynecological CancerChina
-
Chia Tai Tianqing Pharmaceutical Group Co., Ltd.RecruitingAdvanced Endometrial CancerChina
-
Chia Tai Tianqing Pharmaceutical Group Co., Ltd.UnknownStudy of TQB2450 Combined With Anlotinib in Patients With Advanced Non-small Cell Lung Cancer（NSCLC）Non-small Cell Lung CancerChina
-
Peking University People's HospitalPeking University First Hospital; Cancer Institute and Hospital, Chinese Academy... and other collaboratorsUnknownQuality of Life | Advanced Cancer | Chordoma | Effect of DrugsChina
-
University of OklahomaOSI PharmaceuticalsTerminatedPolycythemia VeraUnited States
-
M.D. Anderson Cancer CenterNational Cancer Institute (NCI); Astellas Pharma US, Inc.Completed
-
M.D. Anderson Cancer CenterUnited States Department of DefenseCompletedLung CancerUnited States
-
UNC Lineberger Comprehensive Cancer CenterNational Cancer Institute (NCI); OSI PharmaceuticalsCompletedBladder CancerUnited States
-
University of Alabama at BirminghamOSI PharmaceuticalsTerminatedPancreatic CancerUnited States
-
Hoffmann-La RocheCompletedNon-Small Cell Lung CancerChina
-
SCRI Development Innovations, LLCGlaxoSmithKline; OSI PharmaceuticalsCompletedNon Small Cell Lung CancerUnited States
-
Bristol-Myers SquibbCompletedNon Small Cell Lung CancerKorea, Republic of, Taiwan, United States, Spain, France, Argentina, Canada, Poland
-
OSI PharmaceuticalsCompletedNon-small Cell Lung CancerUnited States, Hungary, Spain, Taiwan, Korea, Republic of, Italy, United Kingdom, Canada, Australia, Belgium, Germany, Austria, Poland, Romania, Argentina, France, Czech Republic, Greece, Russian Federation
-
Michael PradosNational Cancer Institute (NCI); Genentech, Inc.TerminatedAdult Brain TumorsUnited States
-
Amarin Pharma Inc.Completed
-
Andrew B Lassman, MDGenentech, Inc.; OSI PharmaceuticalsCompleted
-
Gilead SciencesGalapagos NVTerminatedPsoriatic ArthritisKorea, Republic of, United States, Taiwan, Australia, Canada, Japan, Poland, Spain, New Zealand, Czechia, Hungary, Bulgaria, Russian Federation
-
M.D. Anderson Cancer CenterNational Cancer Institute (NCI)CompletedMetastatic Skin Squamous Cell Carcinoma | Recurrent Skin Squamous Cell CarcinomaUnited States
-
Montefiore Medical CenterGenentech, Inc.Completed
-
Pasi A. Janne, MD, PhDMassachusetts General Hospital; Dana-Farber Cancer Institute; Beth Israel Deaconess... and other collaboratorsCompletedAdenocarcinoma | Non-small Cell Lung CancerUnited States
-
OSI PharmaceuticalsTerminatedEpendymomaUnited States, Canada, United Kingdom
-
Southwest Oncology GroupNational Cancer Institute (NCI)Completed
-
Kyowa Kirin Co., Ltd.CompletedAdvanced/Recurrent Non-small-cell Lung CancerJapan
-
Hoffmann-La RocheCompletedPancreatic CancerAustralia, Hong Kong, Romania, Germany, Russian Federation, United Kingdom, Bulgaria, Malaysia, Latvia, Slovenia, Croatia, Brazil, Italy, Lithuania, India, Mexico, Singapore, Peru, Ukraine
-
Hoffmann-La RocheCompletedNon-Squamous Non-Small Cell Lung CancerBulgaria
-
Hoffmann-La RocheCompletedNon-Small Cell Lung CancerFinland
-
Hoffmann-La RocheCompletedNon-Small Cell Lung CancerItaly, Spain, Netherlands, France, Germany, United Kingdom
-
PfizerTerminatedCarcinoma, Non-Small-Cell Lung | Carcinoma, Squamous Cell | Carcinoma, Large Cell | Carcinoma, Adenosquamous CellUnited States, Bulgaria, Italy, Spain, Ukraine, Belgium, France, Ireland, Korea, Republic of, Poland, Russian Federation, United Kingdom, Hungary, Serbia, Taiwan, Canada, South Africa, Brazil, Romania, Greece, Puerto Rico, Czech Republic and more
-
Hoffmann-La RocheTerminatedNon-Small Cell Lung CancerUnited States, Canada, France, Poland
-
Hellenic Oncology Research GroupUniversity Hospital of CreteCompleted
-
AZ-VUBHoffmann-La RocheUnknownLung Neoplasms | Non-Small Cell Lung Cancer | Adenocarcinoma, Bronchiolo-AlveolarBelgium
-
NCIC Clinical Trials GroupRoche Pharma AGCompleted
-
Boehringer IngelheimCompletedCarcinoma, Non-Small-Cell LungUnited States, Spain, Taiwan, China, United Kingdom, Denmark, Canada, Korea, Republic of, Germany, Italy, Netherlands, Singapore, Austria, France, Portugal, Greece, India, Mexico, Hungary, Turkey, Argentina, Chile, Ireland
-
Hoffmann-La RocheCompletedNon-Squamous Non-Small Cell Lung CancerItaly
-
Northwell HealthGenentech, Inc.CompletedGlioblastoma Multiforme | Anaplastic AstrocytomaUnited States
-
Northwestern UniversityOSI PharmaceuticalsWithdrawn
-
Alaunos TherapeuticsUnknownAdvanced Solid TumorsUnited States
-
Wuhan Union Hospital, ChinaRecruitingCML-CP; Mutation;Suboptimal Response or Failure in TKIChina
-
Technical University of MunichCompletedAcute Myeloid LeukemiaGermany
-
Nanfang Hospital of Southern Medical UniversityUnknown
-
Hunan Cancer HospitalNot yet recruiting
-
Chia Tai Tianqing Pharmaceutical Group Co., Ltd.Recruiting